Technology
Zepp Health Corporation(ZEPP)
Live Price
Offline$4.83
-7.12% today
1Y Change
+106.56%
Window
Jun 23, 2025 โ Jun 15, 2026
- Market Cap
- $1.76B
- Revenue Growth
- +36.1%
- EPS Growth
- -728.6%
- Dividend Yield
- 0.0%
Coverage: 247 bars ยท Jun 23, 2025 โ Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Zepp Health Corporation (ZEPP) is a Technology stock with a market cap of $1.76B and listed on NYSE. The stock last traded around $4.83 and up 106.6% across the available one-year price window (Jun 23, 2025 โ Jun 15, 2026). Baseline metrics include revenue growth of +36.1%, EPS growth of -728.6%, a dividend yield of 0.0%. What stands out right now is revenue +36.1%, EPS -728.6%, free cash flow -2.3% with operating margin -11.4% and ROIC -6.8%. Valuation is more restrained than many high-expectation growth names at price/sales 1.0. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines ZEPP price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Technology peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+36.1% vs +11.9% peer median
Operating Margin
Below sector median
-11.4% vs +22.0% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 18, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at +36.1% and EPS is at -728.6%, with operating margin around -11.4%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -20.2% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 18, 2026 | โ | -13.6% | -17.5% | โ |
2026 Mar 15, 2026 | โ | -6.5% | -14.0% | -12.9% |
2025 Nov 4, 2025 | โ | -6.0% | -29.2% | -23.9% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
ZEPP
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
ZEPP Max Drawdown
-93.49%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for ZEPP and SPY.
Company Overview
Zepp Health Corporation
New York Stock Exchange
Zepp Health Corporation, together with its subsidiaries, develops, manufactures, and sells smart wearable technological devices in the People's Republic of China. It operates through two segments, Xiaomi Wearable Products, and Self-Branded Products and Others. The company offers smart bands, watches, and scales; and smart hearable products, home treadmill, sportswear, home appliances, and smart watch accessories under the Xiaomi and Amazfit brands. It provides charts and graphs to display analysis of the activity and biometric data collected from users through its Zepp Life and Zepp mobile apps. The company was formerly known as Huami Corporation and changed its name to Zepp Health Corporation in February 2021. Zepp Health Corporation was founded in 2013 and is headquartered in Hefei, the People's Republic of China.
- Leadership
- Wang Huang
- IPO Date
- Feb 8, 2018
- Employees
- 765
- Street Address
- Building B2
- Mailing
- Hefei, 230088
- Region
- Hefei, CN
- Reporting Currency
- USD
- Investor Line
- 86 10 5940 3268
- Last Updated
- May 6, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- 1.0
- Price/Book
- 0.1
Growth
- Revenue
- +36.1%
- EPS
- -728.6%
- Free Cash Flow
- -2.3%
Profitability
- Gross Margin
- 38.5%
- Operating Margin
- -11.4%
- Net Margin
- -15.6%
- ROE
- -17.9%
- ROIC
- -6.8%
Balance Sheet
- Debt/Equity
- 1.06
- Current Ratio
- 1.02
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.